Teladoc Health Q3 2026 Results: Net Loss of $26.9M, Loss Narrows
Teladoc Health reported a revenue decrease to $605.1 million for the third quarter of 2026 compared to $626.4 million in the prior year period. The company's net loss narrowed to $26.9 million, or $0.15 per share, while cash and cash equivalents increased to $849.9 million as of September 30, 2026.
- Key figure
- Net loss $26.9M